Review




Structured Review

Proteintech iba1
Iba1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 386 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10904+1+ap/IBA1+Polyclonal+antibody/us12594323-1124-8-9
Average 96 stars, based on 386 article reviews
iba1 - by Bioz Stars, 2026-09
96/100 stars

Images

Related Articles

Immunofluorescence:

Article Title: The protective effect of Blautia coccoides in secondary injury of intracerebral hemorrhage.
Article Snippet: For Nissl staining, paraÿn sections were immersed in Nissl stain (C0117, Beyotime, China) in an oven at 45◦C for 5 min, and the results were observed under an optical microscope (DMi1, Leica, Germany). .. For immunofluorescence, paraÿn sections were blocked in 2% bovine serum albumin at room temperature for 1 h and incubated with the corresponding primary antibodies (glial fibrillary acidic protein (GFAP), 1:100, 16825-1-AP, Proteintech, China; Ionized calcium-binding adaptor molecule 1 (Iba1), 1:100, 10904-1-AP, Proteintech, China) overnight at 4◦C. .. The following day, sections were incubated with CoraLite488-conjugated Goat Anti-Rabbit IgG (H + L) (SA00013-2; 1:100, Proteintech, China) at room temperature for 2 h. Cells were observed under a confocal microscope (STELLARIS 8, Leica, Germany) in the dark.

Incubation:

Article Title: The protective effect of Blautia coccoides in secondary injury of intracerebral hemorrhage.
Article Snippet: For Nissl staining, paraÿn sections were immersed in Nissl stain (C0117, Beyotime, China) in an oven at 45◦C for 5 min, and the results were observed under an optical microscope (DMi1, Leica, Germany). .. For immunofluorescence, paraÿn sections were blocked in 2% bovine serum albumin at room temperature for 1 h and incubated with the corresponding primary antibodies (glial fibrillary acidic protein (GFAP), 1:100, 16825-1-AP, Proteintech, China; Ionized calcium-binding adaptor molecule 1 (Iba1), 1:100, 10904-1-AP, Proteintech, China) overnight at 4◦C. .. The following day, sections were incubated with CoraLite488-conjugated Goat Anti-Rabbit IgG (H + L) (SA00013-2; 1:100, Proteintech, China) at room temperature for 2 h. Cells were observed under a confocal microscope (STELLARIS 8, Leica, Germany) in the dark.

Article Title: Neuronutritional Enhancement Of Antioxidant Defense System through Nrf2/HO1/NQO1 axis in Fibromyalgia.
Article Snippet: Fibromyalgia (FM) is a disorder characterized by chronic widespread musculoskeletal pain, and it is often accompanied by fatigue, sleep disturbance, and cognitive dysfunction.. Although pathophysiology is multifactorial, increasing evidence highlights the pivotal role of oxidative stress and mitochondrial dysfunction in the development of this condition.. In particular, the Nrf2/HO-1/NQO1 antioxidant axis plays a crucial role in counteracting oxidative damage and maintaining cellular homeostasis.

other:

Article Title: Brain Resident Ly6C hi Monocytes Are Necessary for Maintaining Adult Hippocampal Neurogenesis
Article Snippet: Rabbit anti-mouse Iba1 , proteintech , 10904-1-AP.

Immunohistochemistry:

Article Title: The engineered probiotic strain Lactococcus lactis MG1363-pMG36e-GLP-1 regulates microglial polarization and gut dysbiosis in a transgenic mouse model of Parkinson’s disease
Article Snippet: GLP-1R , Rabbit , 1:200 , Proteintech , 26196-1-AP , AB_2880421 , Immunofluorescence. .. Iba1 , Rabbit , 1:500 , Proteintech , 10904-1-AP , AB_3086348 , Immunohistochemistry. .. GFAP , Mouse , 1:500 , Proteintech , 60190-1-lg , AB_2918946 , Immunohistochemistry.

Western Blot:

Article Title: The engineered probiotic strain Lactococcus lactis MG1363-pMG36e-GLP-1 regulates microglial polarization and gut dysbiosis in a transgenic mouse model of Parkinson’s disease
Article Snippet: p-PI3K , Rabbit , 1:1000 , CST , 17366S , AB_2895293 , Western blotting. .. Ibal , Rabbit , 1:1000 , Proteintech , 10904-1-AP , AB_3086348 , Western blotting. .. GFAP , Mouse , 1:10000 , Proteintech , 60190-1-lg , AB_2918946 , Western blotting.



Similar Products

96
Proteintech iba1
Iba1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10904+1+ap/IBA1+Polyclonal+antibody/us12594323-1124-8-9
Average 96 stars, based on 1 article reviews
iba1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Proteintech anti iba1
Anti Iba1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10904+1+ap/IBA1+Polyclonal+antibody/pm41931282-144-56-64
Average 96 stars, based on 1 article reviews
anti iba1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Proteintech junction molecule 1 iba1
Junction Molecule 1 Iba1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10904+1+ap/IBA1+Polyclonal+antibody/pm41931282-129-55-65
Average 96 stars, based on 1 article reviews
junction molecule 1 iba1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Proteintech iba 1
OExo alleviates LPS-induced microglia activation by suppressing NLRP3 expression (A) Representative images <t>of</t> <t>IBA-1</t> immunostaining reveal the uptake of PKH26-labeled OExo by IBA-1-positive BV-2 microglia after 48 h of incubation. The white arrows highlight the presence of PKH26-labeled OExo surrounding the nuclei of microglia. (B) Representative images of immunostaining for CD206 (top) and iNOS (bottom) demonstrating BV-2 microglia treated with CON (PBS), OExo (50 μg/mL), LPS (100 ng/mL), and LPS combined with OExo (LPS+OExo) for 24 h. (C and D) Quantitative analysis of the fluorescence intensity of CD206 (C) and iNOS (D). n = 6. (E) q-PCR analysis of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α in BV-2 microglia treated with CON, OExo, LPS, and LPS+OExo, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the internal reference gene. n = 9. (F) Representative WB images displaying the expression of CD206, Arg-1, and iNOS in BV-2 cells treated with CON, OExo, LPS, and LPS+OExo, with β-actin as the internal control. Full-length blots are presented in . (G) Statistical analysis of CD206, Arg-1, and iNOS expression levels from WB. n = 6. (H) Representative WB images illustrating the NLRP3, Casp-1, and IL-1β expression levels in BV-2 cells treated with CON, OExo, LPS, LPS+OExo, nigericin, and nigericin+LPS+OExo. nigericin, a NLRP3 activator, was utilized to inhibit the rescuing effects of OExo on LPS-induced NLRP3 activation. β-actin was used as the internal control. Full-length blots are presented in . (I) Statistical analysis of NLRP3, Casp-1, and IL-1β expression levels by WB. n = 4. (J) Representative WB images showing NLRP3 levels in BV-2 cells treated with CON, MExo, OExo, LPS, LPS+MExo and LPS+OExo. β-actin was used as the internal control. Full-length blots are presented in . (K) Statistical analysis of NLRP3 expression levels in (J). n = 4. All western blot quantifications are based on at least three biological replicates, with two to three technical replicates per experiment. Scale bars, 50 μm. DAPI was used for nuclear counterstaining in all images. Data are presented as mean ± SEM. Data are subjected to one-way ANOVA followed by the Tukey’s test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
Iba 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10904+1+ap/IBA1+Polyclonal+antibody/pmc12969089-10-0-2
Average 96 stars, based on 1 article reviews
iba 1 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Proteintech bsa
OExo alleviates LPS-induced microglia activation by suppressing NLRP3 expression (A) Representative images <t>of</t> <t>IBA-1</t> immunostaining reveal the uptake of PKH26-labeled OExo by IBA-1-positive BV-2 microglia after 48 h of incubation. The white arrows highlight the presence of PKH26-labeled OExo surrounding the nuclei of microglia. (B) Representative images of immunostaining for CD206 (top) and iNOS (bottom) demonstrating BV-2 microglia treated with CON (PBS), OExo (50 μg/mL), LPS (100 ng/mL), and LPS combined with OExo (LPS+OExo) for 24 h. (C and D) Quantitative analysis of the fluorescence intensity of CD206 (C) and iNOS (D). n = 6. (E) q-PCR analysis of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α in BV-2 microglia treated with CON, OExo, LPS, and LPS+OExo, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the internal reference gene. n = 9. (F) Representative WB images displaying the expression of CD206, Arg-1, and iNOS in BV-2 cells treated with CON, OExo, LPS, and LPS+OExo, with β-actin as the internal control. Full-length blots are presented in . (G) Statistical analysis of CD206, Arg-1, and iNOS expression levels from WB. n = 6. (H) Representative WB images illustrating the NLRP3, Casp-1, and IL-1β expression levels in BV-2 cells treated with CON, OExo, LPS, LPS+OExo, nigericin, and nigericin+LPS+OExo. nigericin, a NLRP3 activator, was utilized to inhibit the rescuing effects of OExo on LPS-induced NLRP3 activation. β-actin was used as the internal control. Full-length blots are presented in . (I) Statistical analysis of NLRP3, Casp-1, and IL-1β expression levels by WB. n = 4. (J) Representative WB images showing NLRP3 levels in BV-2 cells treated with CON, MExo, OExo, LPS, LPS+MExo and LPS+OExo. β-actin was used as the internal control. Full-length blots are presented in . (K) Statistical analysis of NLRP3 expression levels in (J). n = 4. All western blot quantifications are based on at least three biological replicates, with two to three technical replicates per experiment. Scale bars, 50 μm. DAPI was used for nuclear counterstaining in all images. Data are presented as mean ± SEM. Data are subjected to one-way ANOVA followed by the Tukey’s test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
Bsa, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10904+1+ap/IBA1+Polyclonal+antibody/pm41862054-143-19-35
Average 96 stars, based on 1 article reviews
bsa - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Proteintech gfap
OExo alleviates LPS-induced microglia activation by suppressing NLRP3 expression (A) Representative images <t>of</t> <t>IBA-1</t> immunostaining reveal the uptake of PKH26-labeled OExo by IBA-1-positive BV-2 microglia after 48 h of incubation. The white arrows highlight the presence of PKH26-labeled OExo surrounding the nuclei of microglia. (B) Representative images of immunostaining for CD206 (top) and iNOS (bottom) demonstrating BV-2 microglia treated with CON (PBS), OExo (50 μg/mL), LPS (100 ng/mL), and LPS combined with OExo (LPS+OExo) for 24 h. (C and D) Quantitative analysis of the fluorescence intensity of CD206 (C) and iNOS (D). n = 6. (E) q-PCR analysis of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α in BV-2 microglia treated with CON, OExo, LPS, and LPS+OExo, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the internal reference gene. n = 9. (F) Representative WB images displaying the expression of CD206, Arg-1, and iNOS in BV-2 cells treated with CON, OExo, LPS, and LPS+OExo, with β-actin as the internal control. Full-length blots are presented in . (G) Statistical analysis of CD206, Arg-1, and iNOS expression levels from WB. n = 6. (H) Representative WB images illustrating the NLRP3, Casp-1, and IL-1β expression levels in BV-2 cells treated with CON, OExo, LPS, LPS+OExo, nigericin, and nigericin+LPS+OExo. nigericin, a NLRP3 activator, was utilized to inhibit the rescuing effects of OExo on LPS-induced NLRP3 activation. β-actin was used as the internal control. Full-length blots are presented in . (I) Statistical analysis of NLRP3, Casp-1, and IL-1β expression levels by WB. n = 4. (J) Representative WB images showing NLRP3 levels in BV-2 cells treated with CON, MExo, OExo, LPS, LPS+MExo and LPS+OExo. β-actin was used as the internal control. Full-length blots are presented in . (K) Statistical analysis of NLRP3 expression levels in (J). n = 4. All western blot quantifications are based on at least three biological replicates, with two to three technical replicates per experiment. Scale bars, 50 μm. DAPI was used for nuclear counterstaining in all images. Data are presented as mean ± SEM. Data are subjected to one-way ANOVA followed by the Tukey’s test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
Gfap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10904+1+ap/IBA1+Polyclonal+antibody/pm41862054-143-38-39
Average 96 stars, based on 1 article reviews
gfap - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Proteintech press proteintech
OExo alleviates LPS-induced microglia activation by suppressing NLRP3 expression (A) Representative images <t>of</t> <t>IBA-1</t> immunostaining reveal the uptake of PKH26-labeled OExo by IBA-1-positive BV-2 microglia after 48 h of incubation. The white arrows highlight the presence of PKH26-labeled OExo surrounding the nuclei of microglia. (B) Representative images of immunostaining for CD206 (top) and iNOS (bottom) demonstrating BV-2 microglia treated with CON (PBS), OExo (50 μg/mL), LPS (100 ng/mL), and LPS combined with OExo (LPS+OExo) for 24 h. (C and D) Quantitative analysis of the fluorescence intensity of CD206 (C) and iNOS (D). n = 6. (E) q-PCR analysis of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α in BV-2 microglia treated with CON, OExo, LPS, and LPS+OExo, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the internal reference gene. n = 9. (F) Representative WB images displaying the expression of CD206, Arg-1, and iNOS in BV-2 cells treated with CON, OExo, LPS, and LPS+OExo, with β-actin as the internal control. Full-length blots are presented in . (G) Statistical analysis of CD206, Arg-1, and iNOS expression levels from WB. n = 6. (H) Representative WB images illustrating the NLRP3, Casp-1, and IL-1β expression levels in BV-2 cells treated with CON, OExo, LPS, LPS+OExo, nigericin, and nigericin+LPS+OExo. nigericin, a NLRP3 activator, was utilized to inhibit the rescuing effects of OExo on LPS-induced NLRP3 activation. β-actin was used as the internal control. Full-length blots are presented in . (I) Statistical analysis of NLRP3, Casp-1, and IL-1β expression levels by WB. n = 4. (J) Representative WB images showing NLRP3 levels in BV-2 cells treated with CON, MExo, OExo, LPS, LPS+MExo and LPS+OExo. β-actin was used as the internal control. Full-length blots are presented in . (K) Statistical analysis of NLRP3 expression levels in (J). n = 4. All western blot quantifications are based on at least three biological replicates, with two to three technical replicates per experiment. Scale bars, 50 μm. DAPI was used for nuclear counterstaining in all images. Data are presented as mean ± SEM. Data are subjected to one-way ANOVA followed by the Tukey’s test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
Press Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10904+1+ap/IBA1+Polyclonal+antibody/pm41845487-185-9-10
Average 96 stars, based on 1 article reviews
press proteintech - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Proteintech 1 ap rrid ab 2224377
OExo alleviates LPS-induced microglia activation by suppressing NLRP3 expression (A) Representative images <t>of</t> <t>IBA-1</t> immunostaining reveal the uptake of PKH26-labeled OExo by IBA-1-positive BV-2 microglia after 48 h of incubation. The white arrows highlight the presence of PKH26-labeled OExo surrounding the nuclei of microglia. (B) Representative images of immunostaining for CD206 (top) and iNOS (bottom) demonstrating BV-2 microglia treated with CON (PBS), OExo (50 μg/mL), LPS (100 ng/mL), and LPS combined with OExo (LPS+OExo) for 24 h. (C and D) Quantitative analysis of the fluorescence intensity of CD206 (C) and iNOS (D). n = 6. (E) q-PCR analysis of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α in BV-2 microglia treated with CON, OExo, LPS, and LPS+OExo, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the internal reference gene. n = 9. (F) Representative WB images displaying the expression of CD206, Arg-1, and iNOS in BV-2 cells treated with CON, OExo, LPS, and LPS+OExo, with β-actin as the internal control. Full-length blots are presented in . (G) Statistical analysis of CD206, Arg-1, and iNOS expression levels from WB. n = 6. (H) Representative WB images illustrating the NLRP3, Casp-1, and IL-1β expression levels in BV-2 cells treated with CON, OExo, LPS, LPS+OExo, nigericin, and nigericin+LPS+OExo. nigericin, a NLRP3 activator, was utilized to inhibit the rescuing effects of OExo on LPS-induced NLRP3 activation. β-actin was used as the internal control. Full-length blots are presented in . (I) Statistical analysis of NLRP3, Casp-1, and IL-1β expression levels by WB. n = 4. (J) Representative WB images showing NLRP3 levels in BV-2 cells treated with CON, MExo, OExo, LPS, LPS+MExo and LPS+OExo. β-actin was used as the internal control. Full-length blots are presented in . (K) Statistical analysis of NLRP3 expression levels in (J). n = 4. All western blot quantifications are based on at least three biological replicates, with two to three technical replicates per experiment. Scale bars, 50 μm. DAPI was used for nuclear counterstaining in all images. Data are presented as mean ± SEM. Data are subjected to one-way ANOVA followed by the Tukey’s test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
1 Ap Rrid Ab 2224377, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10904+1+ap/IBA1+Polyclonal+antibody/pmc13006394-8-6-4
Average 96 stars, based on 1 article reviews
1 ap rrid ab 2224377 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


OExo alleviates LPS-induced microglia activation by suppressing NLRP3 expression (A) Representative images of IBA-1 immunostaining reveal the uptake of PKH26-labeled OExo by IBA-1-positive BV-2 microglia after 48 h of incubation. The white arrows highlight the presence of PKH26-labeled OExo surrounding the nuclei of microglia. (B) Representative images of immunostaining for CD206 (top) and iNOS (bottom) demonstrating BV-2 microglia treated with CON (PBS), OExo (50 μg/mL), LPS (100 ng/mL), and LPS combined with OExo (LPS+OExo) for 24 h. (C and D) Quantitative analysis of the fluorescence intensity of CD206 (C) and iNOS (D). n = 6. (E) q-PCR analysis of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α in BV-2 microglia treated with CON, OExo, LPS, and LPS+OExo, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the internal reference gene. n = 9. (F) Representative WB images displaying the expression of CD206, Arg-1, and iNOS in BV-2 cells treated with CON, OExo, LPS, and LPS+OExo, with β-actin as the internal control. Full-length blots are presented in . (G) Statistical analysis of CD206, Arg-1, and iNOS expression levels from WB. n = 6. (H) Representative WB images illustrating the NLRP3, Casp-1, and IL-1β expression levels in BV-2 cells treated with CON, OExo, LPS, LPS+OExo, nigericin, and nigericin+LPS+OExo. nigericin, a NLRP3 activator, was utilized to inhibit the rescuing effects of OExo on LPS-induced NLRP3 activation. β-actin was used as the internal control. Full-length blots are presented in . (I) Statistical analysis of NLRP3, Casp-1, and IL-1β expression levels by WB. n = 4. (J) Representative WB images showing NLRP3 levels in BV-2 cells treated with CON, MExo, OExo, LPS, LPS+MExo and LPS+OExo. β-actin was used as the internal control. Full-length blots are presented in . (K) Statistical analysis of NLRP3 expression levels in (J). n = 4. All western blot quantifications are based on at least three biological replicates, with two to three technical replicates per experiment. Scale bars, 50 μm. DAPI was used for nuclear counterstaining in all images. Data are presented as mean ± SEM. Data are subjected to one-way ANOVA followed by the Tukey’s test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

Journal: iScience

Article Title: Cerebral organoid exosomes reversed behavioral deficits by repressing NLRP3-mediated neuroinflammation in stress models

doi: 10.1016/j.isci.2026.115069

Figure Lengend Snippet: OExo alleviates LPS-induced microglia activation by suppressing NLRP3 expression (A) Representative images of IBA-1 immunostaining reveal the uptake of PKH26-labeled OExo by IBA-1-positive BV-2 microglia after 48 h of incubation. The white arrows highlight the presence of PKH26-labeled OExo surrounding the nuclei of microglia. (B) Representative images of immunostaining for CD206 (top) and iNOS (bottom) demonstrating BV-2 microglia treated with CON (PBS), OExo (50 μg/mL), LPS (100 ng/mL), and LPS combined with OExo (LPS+OExo) for 24 h. (C and D) Quantitative analysis of the fluorescence intensity of CD206 (C) and iNOS (D). n = 6. (E) q-PCR analysis of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α in BV-2 microglia treated with CON, OExo, LPS, and LPS+OExo, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the internal reference gene. n = 9. (F) Representative WB images displaying the expression of CD206, Arg-1, and iNOS in BV-2 cells treated with CON, OExo, LPS, and LPS+OExo, with β-actin as the internal control. Full-length blots are presented in . (G) Statistical analysis of CD206, Arg-1, and iNOS expression levels from WB. n = 6. (H) Representative WB images illustrating the NLRP3, Casp-1, and IL-1β expression levels in BV-2 cells treated with CON, OExo, LPS, LPS+OExo, nigericin, and nigericin+LPS+OExo. nigericin, a NLRP3 activator, was utilized to inhibit the rescuing effects of OExo on LPS-induced NLRP3 activation. β-actin was used as the internal control. Full-length blots are presented in . (I) Statistical analysis of NLRP3, Casp-1, and IL-1β expression levels by WB. n = 4. (J) Representative WB images showing NLRP3 levels in BV-2 cells treated with CON, MExo, OExo, LPS, LPS+MExo and LPS+OExo. β-actin was used as the internal control. Full-length blots are presented in . (K) Statistical analysis of NLRP3 expression levels in (J). n = 4. All western blot quantifications are based on at least three biological replicates, with two to three technical replicates per experiment. Scale bars, 50 μm. DAPI was used for nuclear counterstaining in all images. Data are presented as mean ± SEM. Data are subjected to one-way ANOVA followed by the Tukey’s test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

Article Snippet: IBA-1 , Protein tech; Wako , Cat# 10904-1-AP; Cat# 019-19741.

Techniques: Activation Assay, Expressing, Immunostaining, Labeling, Incubation, Fluorescence, Control, Western Blot

Intranasal administration of OExo attenuated microglia activation in the hippocampus in mouse stress models (A) Representative images of immunofluorescence staining for IBA-1 showing PKH26-labeled OExo co-localized with IBA-1-positive microglia in the hippocampus 24 h after intranasal administration of OExo. Nuclei were counterstained with DAPI. The region within the white dashed box is enlarged in the lower image. White arrows indicate PKH26-labeled exosomes surrounding DAPI-stained nuclei in IBA-1-positive microglia. (B) Low-magnification representative images of IBA-1 and DAPI staining showing the hippocampal subregions CA1, CA3, and DG. (C) Representative immunofluorescence images of IBA-1 in the hippocampal CA1, CA3, and DG subregions. Insets show magnified views of the regions within the dashed boxes. (D) Quantitative analysis of IBA-1-positive microglia in the CA1, CA3, and DG subregions. n = 6. (E) qPCR analysis of pro-inflammatory cytokines ( IL-6 , IL-1β , and TNF-α ) in the hippocampus. GAPDH was used as the internal reference gene. n = 9. (F) Representative western blot images of Arg-1 and iNOS protein expression in the hippocampus. β-actin was used as the loading control. Full-length blots are presented in . (G) Representative WB images of NF-κB, p-NF-κB, NLRP3, IL-1β, and Casp-1 protein expression in the hippocampus. β-actin was used as the loading control. Full-length blots are presented in . (H) Quantitative analysis of Arg-1 and iNOS protein expression from western blot data. n = 6. (I) Quantitative analysis of NF-κB, p-NF-κB, NLRP3, IL-1β, and Casp-1 protein expression from WB data. n = 6. (J) Representative double immunofluorescence staining of NLRP3 and IBA-1 in the hippocampus. The regions within the white dashed boxes are enlarged in the right image. White arrows indicate cells positive for both NLRP3 and IBA-1. (K) Quantitative analysis of cells positive for both NLRP3 and IBA-1 among IBA-1-positive microglia in the hippocampus. n = 6. Scale bars, 20 μm (upper) and 10 μm (bottom) in (A); 1,000 μm in (B); 100 μm in (C); and 20 μm in the magnified insets of (C) and 50 μm in (J). Data are presented as mean ± SEM. The interaction between CMS and OExo was evaluated using two-way ANOVA followed by Tukey’s test (details are shown in ). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

Journal: iScience

Article Title: Cerebral organoid exosomes reversed behavioral deficits by repressing NLRP3-mediated neuroinflammation in stress models

doi: 10.1016/j.isci.2026.115069

Figure Lengend Snippet: Intranasal administration of OExo attenuated microglia activation in the hippocampus in mouse stress models (A) Representative images of immunofluorescence staining for IBA-1 showing PKH26-labeled OExo co-localized with IBA-1-positive microglia in the hippocampus 24 h after intranasal administration of OExo. Nuclei were counterstained with DAPI. The region within the white dashed box is enlarged in the lower image. White arrows indicate PKH26-labeled exosomes surrounding DAPI-stained nuclei in IBA-1-positive microglia. (B) Low-magnification representative images of IBA-1 and DAPI staining showing the hippocampal subregions CA1, CA3, and DG. (C) Representative immunofluorescence images of IBA-1 in the hippocampal CA1, CA3, and DG subregions. Insets show magnified views of the regions within the dashed boxes. (D) Quantitative analysis of IBA-1-positive microglia in the CA1, CA3, and DG subregions. n = 6. (E) qPCR analysis of pro-inflammatory cytokines ( IL-6 , IL-1β , and TNF-α ) in the hippocampus. GAPDH was used as the internal reference gene. n = 9. (F) Representative western blot images of Arg-1 and iNOS protein expression in the hippocampus. β-actin was used as the loading control. Full-length blots are presented in . (G) Representative WB images of NF-κB, p-NF-κB, NLRP3, IL-1β, and Casp-1 protein expression in the hippocampus. β-actin was used as the loading control. Full-length blots are presented in . (H) Quantitative analysis of Arg-1 and iNOS protein expression from western blot data. n = 6. (I) Quantitative analysis of NF-κB, p-NF-κB, NLRP3, IL-1β, and Casp-1 protein expression from WB data. n = 6. (J) Representative double immunofluorescence staining of NLRP3 and IBA-1 in the hippocampus. The regions within the white dashed boxes are enlarged in the right image. White arrows indicate cells positive for both NLRP3 and IBA-1. (K) Quantitative analysis of cells positive for both NLRP3 and IBA-1 among IBA-1-positive microglia in the hippocampus. n = 6. Scale bars, 20 μm (upper) and 10 μm (bottom) in (A); 1,000 μm in (B); 100 μm in (C); and 20 μm in the magnified insets of (C) and 50 μm in (J). Data are presented as mean ± SEM. The interaction between CMS and OExo was evaluated using two-way ANOVA followed by Tukey’s test (details are shown in ). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

Article Snippet: IBA-1 , Protein tech; Wako , Cat# 10904-1-AP; Cat# 019-19741.

Techniques: Activation Assay, Immunofluorescence, Staining, Labeling, Western Blot, Expressing, Control, Double Immunofluorescence Staining